Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 94.73% is 193% above its 5-year average of 32.38%, near the high end of its 5-year range (0.00%–100.00%).
1.32% below its 12-month average of 96.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 98.84%.
GROSS MARGIN
94.73%
GROSS MARGIN AVG TTM
96.00%
GROSS MARGIN AVG 3Y
52.31%
GROSS MARGIN AVG 5Y
32.38%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
0.00%
GROSS MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
-1.32%
CURRENT VS 3Y AVG
+81.11%
CURRENT VS 5Y AVG
+192.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
+140.92%
vs the sector median at left
Kura Oncology, Inc.
Market Cap
$965.87M
Gross Margin
94.73%
TTM Avg
96.00%
3Y Avg
52.31%
5Y Avg
32.38%
Market Cap
$950.06M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$948.40M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$987.89M
Gross Margin
79.21%
TTM Avg
77.54%
3Y Avg
74.46%
5Y Avg
74.10%
Market Cap
$997.50M
Gross Margin
63.74%
TTM Avg
62.39%
3Y Avg
56.59%
5Y Avg
42.69%
Market Cap
$999.72M
Gross Margin
97.19%
TTM Avg
61.28%
3Y Avg
80.64%
5Y Avg
87.09%
Market Cap
$999.73M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
50.00%
Market Cap
$1.01B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $965.87M | 94.73% | 96.00% | 52.31% | 32.38% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $950.06M | 100.00% | 100.00% | 100.00% | 100.00% |
| MoonLake Immunotherapeutics (MLTX)vs › | $948.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pacira BioSciences, Inc. (PCRX)vs › | $987.89M | 79.21% | 77.54% | 74.46% | 74.10% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $997.50M | 63.74% | 62.39% | 56.59% | 42.69% |
| MeiraGTx Holdings plc (MGTX)vs › | $999.72M | 97.19% | 61.28% | 80.64% | 87.09% |
| Aktis Oncology, Inc. (AKTS)vs › | $999.73M | 100.00% | 100.00% | 50.00% | 50.00% |
| CeriBell, Inc. (CBLL)vs › | $931.08M | 88.90% | 87.31% | 85.47% | 85.47% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | 0.00% | 0.00% | 0.00% | 0.00% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
Gross Margin
94.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 98.84% |
| 2026-03-31 | 96.62% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 84.52% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
